No results found for “”
No results found for filter “”
-
Statements & press releases 08.04.21
All Together. No One Left Behind: Delays and the unavailability of medicines harm patients
Working together to address the root causes of delays and unavailability of medicines
Read Article -
Statements & press releases 30.03.21
EFPIA – Vaccines Europe response to global leaders urgent call for international pandemic treaty
The devastating human and economic cost of the COVID-19 pandemic has underlined the need for a global response.
Read Article -
Statements & press releases 26.03.21
EFPIA statement in response to the Council compromise agreement on the Commission Proposal for a Regulation...
Unfortunately, we regret that the Member States’ compromise risks creating a more inefficient system
Read Article -
Blog articles 26.03.21
A healthy pipeline: will new innovations deliver for patients?
New therapies and vaccines could improve lives and transform healthcare – if we are ready to embrace them
Read Article -
Blog articles 25.03.21
Podcast: Should Europe relocate pharmaceutical production to within the EU?
Welcome to 19 conversations
Read Article -
Blog articles 24.03.21
Podcast: How can monoclonal antibodies help in the fight against COVID-19?
Welcome to 19 Conversations
Read Article -
Statements & press releases 23.03.21
EU vaccine roll out: Putting hard-won progress in jeopardy
When the European Council gathers virtually later this week, it remains critical to avoid reactionary proposals that could disrupt the production and delivery...
Read Article -
Blog articles 18.03.21
Why I am #TeamVaccines (Guest blog)
Dr Paul Robinson from MSD spends 2-3 half days a week vaccinating people against COVID-19, and says the sense of relief when that first vaccine goes in...
Read Article -
Blog articles 16.03.21
IMI Impact: Driving healthcare’s digital future
The Innovative Medicines Initiative is making it easier to share and use health data for research and care
Read Article -
Blog articles 15.03.21
Podcast: Is intellectual property a barrier to access?
Welcome to 19 Conversations
Read Article -
Blog articles 12.03.21
Life, loss and connection: Why I am #TeamVaccines
It is together, by being part of this unprecedented vaccination programme, that we can all play a role in reconnecting with each other. It is what my Dad’s...
Read Article -
Blog articles 09.03.21
Podcast: How can we future-proof medicines regulation in the post-COVID world?
Welcome to 19 conversations
Read Article
No results found for “”
No results found for filter “”
-
EFPIA News 03.12.20
Working together towards better patient outcomes
A new series of short films to showcase innovative partnerships that will change patient outcomes
Read Article -
EFPIA News 14.10.20
Biopharmaceutical industry support EU regulators exceptional transparency measures
And call other regulatory authorities to follow suit to help ensure confidence in the science and the decision-making
Read Article -
EFPIA News 17.09.20
Vaccines Europe Statement on the safety of COVID-19 vaccines
The health and safety of people receiving any vaccine is our first priority, and that applies equally to recipients of a COVID-19 vaccine
Read Article -
EFPIA News 10.06.20
Connecting Healthcare Awards - Submission period extended
The new deadline is 30 September 2020
Read Article -
EFPIA News 23.04.20
Europe’s COVID-19 battle: Getting the data we need to ensure the supply of medicines
A major part of the solution is the provision of detailed, accurate forecasting data from the European Centre for Disease Control (ECDC) on the patient-level...
Read Article -
EFPIA News 22.04.20
Coronavirus – your questions answered
What is the industry in Europe doing to help in the fight against the coronavirus? What are the risks of drug shortage caused by the coronavirus?
Read Article -
EFPIA News 20.04.20
Exscalate4Cov project: Call for Collaboration by DG Connect
The European Commission (DG Connect) is looking for industry partners to join the Exscalate4Cov project, seeking to accelerate identification of medicines...
Read Article -
EFPIA News 08.04.20
Official Update on the Connecting Healthcare Awards
A special COVID-19 category now available
Read Article -
EFPIA News 05.03.20
Connecting Healthcare Awards 2020 – Apply Now
Turn the spotlight on collaborative projects that make a difference to patients across Europe
Read Article -
EFPIA News 05.03.20
EFPIA's input to the EU's Beating Cancer Plan Roadmap consultation
The research-based pharmaceutical industry remains committed to improving cancer prevention, diagnosis, treatment and quality of life of patients.
Read Article -
EFPIA News 20.02.20
IMI opens registrations for a webinar on the Coronavirus Call
The Innovative Medicines Initiative to launch EUR 45 million Call for proposals on COVID-19 early March
Read Article -
EFPIA News 10.02.20
EFPIA, Medicines for Europe and AESGP call for a Mutual Recognition Agreement on Good Manufacturing Practice...
The pharmaceutical industry in Europe has worked to support the EU27 and UK to reach an agreement that will allow patients to receive medicines and medical...
Read Article
No results found for “”
No results found for filter “”
-
Statements & press releases 08.04.21
All Together. No One Left Behind: Delays and the unavailability of medicines harm patients
Working together to address the root causes of delays and unavailability of medicines
Read Article -
Statements & press releases 30.03.21
EFPIA – Vaccines Europe response to global leaders urgent call for international pandemic treaty
The devastating human and economic cost of the COVID-19 pandemic has underlined the need for a global response.
Read Article -
Statements & press releases 26.03.21
EFPIA statement in response to the Council compromise agreement on the Commission Proposal for a Regulation...
Unfortunately, we regret that the Member States’ compromise risks creating a more inefficient system
Read Article -
Statements & press releases 23.03.21
EU vaccine roll out: Putting hard-won progress in jeopardy
When the European Council gathers virtually later this week, it remains critical to avoid reactionary proposals that could disrupt the production and delivery...
Read Article -
Statements & press releases 03.03.21
Maintaining the exchange of critical health data
An adequacy decision on the UK data protection regime
Read Article -
Statements & press releases 01.03.21
EU Structured Dialogue on Supply Chain Security: evidence, partnership and global resilience
To remain competitive, Europe needs longer-term investment, incentives and global regulatory harmonisation
Read Article -
Statements & press releases 23.02.21
Unlocking the potential of precision medicine in Europe – Improving cancer care through broader access...
Biomarkers and biomarker testing are a significant pillar of precision medicine, which uses patient data to inform personalised treatment decisions.
Read Article -
Statements & press releases 23.02.21
Transforming health research & innovation in Europe: A Joint Statement on the European Partnership for...
Health industry stakeholders welcome the Commission’s proposal for a European Partnership for Health Innovation under Horizon Europe.
Read Article -
Statements & press releases 22.02.21
EFPIA statement on EU Trade Strategy
The COVID-19 pandemic has underlined the importance of global cooperation and well-functioning global supply chains
Read Article -
Statements & press releases 09.02.21
EFPIA response to the Cross-border Healthcare Directive
Giving patients access to safe and high-quality healthcare and encouraging cooperation across the European Union
Read Article -
Statements & press releases 09.02.21
Using the FMD Data Repositories for Shortages Monitoring
Patient health and safety is of the utmost importance to the stakeholders that have put every effort in place to implement safety features and set up the...
Read Article -
Statements & press releases 03.02.21
AESGP, EFPIA and Medicines for Europe joint reflections on EMA-HMA-EC Key principles for electronic Product...
This paper aims to highlight key asks and identify key actions in order to move the ePI project from principles to action.
Read Article
No results found for “”
No results found for filter “”
-
Blog articles 26.03.21
A healthy pipeline: will new innovations deliver for patients?
New therapies and vaccines could improve lives and transform healthcare – if we are ready to embrace them
Read Article -
Blog articles 25.03.21
Podcast: Should Europe relocate pharmaceutical production to within the EU?
Welcome to 19 conversations
Read Article -
Blog articles 24.03.21
Podcast: How can monoclonal antibodies help in the fight against COVID-19?
Welcome to 19 Conversations
Read Article -
Blog articles 18.03.21
Why I am #TeamVaccines (Guest blog)
Dr Paul Robinson from MSD spends 2-3 half days a week vaccinating people against COVID-19, and says the sense of relief when that first vaccine goes in...
Read Article -
Blog articles 16.03.21
IMI Impact: Driving healthcare’s digital future
The Innovative Medicines Initiative is making it easier to share and use health data for research and care
Read Article -
Blog articles 15.03.21
Podcast: Is intellectual property a barrier to access?
Welcome to 19 Conversations
Read Article -
Blog articles 12.03.21
Life, loss and connection: Why I am #TeamVaccines
It is together, by being part of this unprecedented vaccination programme, that we can all play a role in reconnecting with each other. It is what my Dad’s...
Read Article -
Blog articles 09.03.21
Podcast: How can we future-proof medicines regulation in the post-COVID world?
Welcome to 19 conversations
Read Article -
Blog articles 03.03.21
Learnings from COVID-19: Partnerships leading the way for clinical trial modernisation (Guest blog)
Platform trials would prove especially helpful in rare disease research. Since these illnesses affect small to very small numbers of patients, traditional...
Read Article -
Blog articles 01.03.21
Bringing new cancer treatments to European patients: The challenge of making it across all three access...
Let’s take a look at the overall picture of bringing new cancer treatments to European patients across all three access milestones.
Read Article -
Blog articles 01.03.21
A formula for vaccine breakthroughs
Intellectual property is a key ingredient in COVID-19 vaccine development
Read Article -
Blog articles 25.02.21
From diagnosis to awareness
Innovation has to be about patients, and everyone who lives with a disease, however common or rare, deserves the chance for a normal life.
Read Article